Sanjay Popat, Benjamin Besse, Antonio Calles, Fabiana Letizia Letizia Cecere, Byoung Chul Cho, Roberto Ferrara, Domenico Galetta, Adrianus Johannes De Langen, Dae Ho Lee, Filippo de Marinis, Ana Rodrigues, Luis Corrales, Sophia Wang, Abe Fong, Enriqueta Felip. "Efficacy and safety of pralsetinib as first-line treatment of RET fusion–positive advanced or metastatic non–small cell lung cancer (NSCLC): The phase 3 AcceleRET-Lung study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8504